Jamil Khurram

Chief Medical Officer

Jamil Khurram has filed 8 SEC Form 4 filings (30 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.

On the most recent filing, Jamil Khurram is listed as Chief Medical Officer at GALECTIN THERAPEUTICS INC. Inside the rolling window, Jamil Khurram reported no open-market purchases and 11 open-market sales totaling $1.2M in GALT. The largest disclosed transaction in the window is a sale of 79,617 GALT shares on Nov 13, 2025, worth $436K.

Companies traded

Other insiders at GALT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
GALTSale$83KJul 16SEC ↗
GALTSale$23KJun 30SEC ↗
GALTSale$239KJun 30SEC ↗
GALTSale$24KJun 25SEC ↗
GALTSale$2KMay 28SEC ↗
GALTSale$55KJan 6SEC ↗
GALTSale$99KJan 6SEC ↗
GALTSale$78KJan 6SEC ↗
GALTSale$33KJan 5SEC ↗
GALTSale$137KDec 19SEC ↗
GALTSale$436KNov 14SEC ↗
Showing 1–11 of 11
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Jamil Khurram made?

Jamil Khurram has filed 8 SEC Form 4 filings (30 transaction rows) across 1 company since 2025.

Which companies does Jamil Khurram trade?

Jamil Khurram has filed SEC Form 4 disclosures for 1 company, including GALT.

When was Jamil Khurram's most recent SEC Form 4 filing?

Jamil Khurram's most recent SEC Form 4 filing on Tracefour is dated Jul 16, 2026.

What is Jamil Khurram's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Jamil Khurram is listed as Chief Medical Officer.

What is Jamil Khurram's total buy and sell value in the current window?

Inside the rolling retention window, Jamil Khurram bought $0 and sold $1.2M based on SEC Form 4 filings.

What was Jamil Khurram's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 79,617 GALT shares on 2025-11-13, worth $436K, per SEC Form 4 filings.